Your browser doesn't support javascript.
loading
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure.
Komarnicki, Pawel; Gut, Pawel; Musialkiewicz, Jan; Cieslewicz, Maja; Maciejewski, Adam; Patel, Prachi; Mastorakos, George; Ruchala, Marek.
Affiliation
  • Komarnicki P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Gut P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Musialkiewicz J; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Cieslewicz M; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Maciejewski A; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Patel P; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Mastorakos G; Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Ruchala M; Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Endocr Connect ; 12(10)2023 Oct 01.
Article in En | MEDLINE | ID: mdl-37552533

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Endocr Connect Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Prognostic_studies Language: En Journal: Endocr Connect Year: 2023 Document type: Article Affiliation country: